(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SMR²T BY MIMEDX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

SMR²T BY MIMEDX

ST13

US500000088718272

Class

5

Filing

88718272

Registration

6531459

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

07/31/2025

Trademark type

Combined

Nice classes

5

Filing date

12/06/2019

Registration date

10/19/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/19/2021

Last transaction

07/31/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/21/2021

First use in commerce

06/21/2021

Drawing code

5

Owner type

03

Owner location

Marietta, GA

Examiner

MACFARLANE, JAMES

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the wording "SMR²T BY MIMDEX" in a stylized font, with the number "2" in superscript.

Holders and representatives

Holders

MiMedx Group, Inc.

Representatives

Marcy L. Sperry, Esq. Sperry IP Law LLC dba Vivid IP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Topical treatment in the nature of a wound dressing for medical use for the treatment of woundsulcersburnsscars and surgical incisions; Topical treatment in the nature of an allograft for medical use for the treatment of woundsulcersburnsscars and surgical incisions; topical treatment made from amniotic material in the nature of a wound dressing for medical use for the treatment of woundsulcersburnsscars and surgical incisions; topical treatment made from amniotic material in the nature of an allograft for medical use for the treatment of woundsulcersburnsscars and surgical incisions; wound treatment in the nature of a micronized powder comprising amniotic material for medical purposes; wound treatment in the nature of a dressing comprising amniotic material; allograft made from amniotic material

Publications

History of USPTO decisions and trademark events.

32 publications found

R.PR

REGISTERED-PRINCIPAL REGISTER

10/19/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

09/15/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/14/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/13/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/13/2021

IUAF

USE AMENDMENT FILED

08/03/2021

EISU

TEAS STATEMENT OF USE RECEIVED

08/03/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/18/2021

EX1G

SOU EXTENSION 1 GRANTED

02/16/2021

EXT1

SOU EXTENSION 1 FILED

02/16/2021

EEXT

SOU TEAS EXTENSION RECEIVED

02/16/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

09/22/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/28/2020

PUBO

PUBLISHED FOR OPPOSITION

07/28/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/08/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/24/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/28/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/28/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/28/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/03/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/03/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/03/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/03/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/03/2020

CEPE

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED

03/17/2020

ALIE

ASSIGNED TO LIE

03/17/2020

GEAN

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

03/16/2020

GEAP

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

03/16/2020

CPEA

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

03/16/2020

DOCK

ASSIGNED TO EXAMINER

03/07/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/11/2019

NWAP

NEW APPLICATION ENTERED

12/10/2019

Continuous trademark protection

Get notified about every new filing that threatens SMR²T BY MIMEDX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.